Harvard Business Review

AUGUST 8, 2018

But how well schools meet this goal, and to what extent their teaching influences their students’ leadership, is an open question. As chief executive, Dolan followed the agency-theoretic prescription that was taught in business schools in the late 1970s, refocusing his company’s business almost exclusively on pharmaceuticals.

Influence 12

Influence Education Pharmaceuticals Finance 12

The Horizons Tracker

NOVEMBER 29, 2023

Broad experience A broader range of educational backgrounds within corporate leadership can offer valuable perspectives and a more expansive outlook when confronted with uncertain circumstances. Their advisory board consists of individuals with educational backgrounds in fields such as medical sciences, economics, journalism, and finance.

Diversity 94

Diversity Innovation Biotechnology Short-term 94

Chartered Management Institute

FEBRUARY 26, 2024

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

Uncertainty 52

Uncertainty Risk Management Training Compliance 52

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

NOVEMBER 10, 2017

Spending on corporate learning, particularly leadership development, continues to increase at a staggering pace. According to one piece of research , spending on frontline leadership development alone increased by over 310% in a three-year period. Pat Canova/Getty Images. Insight center. The Gap Between Strategy and Execution.

Skills 11

Skills Agility Learning-by-Doing Content 11

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. Consider the legal field.

Career 8

Career Skills Health Care Pharmaceuticals 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. We came back from China excited about the potential contribution this country can make to a sustainable economy and society for itself and the leadership it can provide for the rest of the world. Stay tuned.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

MAY 15, 2013

finance vs. marketing) and units (e.g. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm). Leadership Organizational culture' The cultures of organizations are never monolithic. There are many factors that drive internal variations in the culture of business functions (e.g.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. In these cases, running the numbers and grasping what they tell you is important, but it isn’t enough. With gray area problems, you have to look hard at the economics and look past the economics. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Mills Scofield

NOVEMBER 11, 2014

This is taken from The Intercollegiate Finance Journal (IFJ) is an undergraduate student-run journal about how current finance, economics, business and technology issues affect students'' lives. Please consider supporting the IFJ to ensure that our youth''s voices are heard and heeded. ~~~~~~~~~~~~~~~~~~~~~~~~~~~.

Finance 131

Finance Incentives Education Pharmaceuticals 131

Harvard Business Review

AUGUST 23, 2016

Our limited sample suggests that both groups agree that board leadership should serve as champions of board diversity, but they differ on the policies they advocate to increase board diversity. Both Republicans and Democrats say the most effective board committee is audit/finance.

Politics 8

Politics Committee Telecommunications Diversity 8